EGFR and non-small cell lung carcinoma: In a previous meta‐analysis of 22 studies that included NSCLC patients with or without EGFR mutations, the presence of an EGFR mutation was associated with a markedly higher incidence of subsequent brain metastasis and an increasing trend in the incidence of initial brain metastasis.22